Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Oncology|December 24, 2013
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trialHelena M Earl, Anne-Laure Vallier, Louise Hiller, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis TrialJeremy St John Thomas, Elena Provenzano, Louise Hiller, et al.Cancer Research|November 8, 2024
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast CancerAbigail Shea, Yaniv Eyal-Lubling, Daniel Guerrero-Romero, et al.Nature Communications|May 11, 2016
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesBernard Pereira, Suet-Feung Chin, Oscar M Rueda, et al.International Journal of Epidemiology|December 13, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysisQi Guo, Stephen Burgess, Constance Turman, et al.Breast Cancer Research : BCR|April 22, 2015
Common germline polymorphisms associated with breast cancer-specific survivalAilith Pirie, Qi Guo, Peter Kraft, et al.Nature Communications|January 18, 2020
A network analysis to identify mediators of germline-driven differences in breast cancer prognosisMaria Escala-Garcia, Jean Abraham, Irene L Andrulis, et al.British Journal of Cancer|February 22, 2019
Genome-wide association study of germline variants and breast cancer-specific mortalityMaria Escala-Garcia, Qi Guo, Thilo Dörk, et al.Pageof 4